Human monocytes have prothrombin cleaving activity

Insights

Human monocytes generate fibrin on their surfaces using thrombin (a clotting protein). This process requires factor II (prothrombin) and suggests monocytes have a prothrombin-cleaving ability crucial for tissue repair.

Area of Science:

  • Hematology
  • Cell Biology
  • Biochemistry

Background:

  • Human monocytes can form fibrin on their surfaces upon plasma exposure.
  • The specific coagulation factors involved in this monocyte-derived fibrin formation are not fully elucidated.

Purpose of the Study:

  • To investigate the role of coagulation factors in monocyte-induced fibrin formation.
  • To determine if monocytes possess intrinsic procoagulant activity.

Main Methods:

  • Testing monocyte fibrin formation in various factor-deficient plasmas.
  • Utilizing a thrombin-specific inhibitor (hirudin) to assess thrombin's role.
  • Measuring monocyte prothrombin cleavage over time.

Main Results:

  • Monocyte fibrin formation was impaired only in factor II (prothrombin) deficient plasma.
  • Hirudin inhibited fibrin formation, confirming thrombin's necessity.
  • Monocytes demonstrated an increasing ability to cleave prothrombin to thrombin with incubation time.

Conclusions:

  • Human monocytes possess a prothrombin-cleaving activity, generating thrombin necessary for fibrin formation.
  • Thrombin likely plays a significant role in monocyte-mediated wound healing and tissue repair processes.

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...